- £1.83bn
- £7.83bn
- £2.96bn
- 47
- 40
- 93
- 65
2019 December 31st | C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,653 | 2,432 | 2,228 | 2,751 | 2,960 |
Cost of Revenue | |||||
Gross Profit | 566 | 355 | 312 | 591 | 740 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,365 | 2,782 | 2,315 | 2,604 | 2,815 |
Operating Profit | 288 | -350 | -87.4 | 147 | 145 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 55.9 | -613 | -259 | -105 | -189 |
Provision for Income Taxes | |||||
Net Income After Taxes | 78.2 | -645 | -270 | -73 | -216 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 451 | -647 | -205 | -69 | -215 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 451 | -647 | -205 | -69 | -215 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.109 | -0.361 | -0.227 | -0.021 | -0.095 |
Dividends per Share |